Skip to main content

Table 2 CMR characteristics of control subjects versus patients with PH

From: Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study

  Normal PH patient p-value
RVEDV (mL) 130 (104–156) 158 (128–204) 0.0056
RVESV (mL) 38 (31–63) 103 (70–133) <0.00001*
RVSV (mL) 87 (74–99) 62 (48–75) 0.0006*
RVEF 65 ± 8 40 ± 12 <0.00001*
LVEDV (mL) 134 (108–139) 88 (74–109) 0.0001*
LVESV (mL) 42 ± 16 32 ± 13 0.012
LVSV (mL) 85 ± 19 62 ± 18 <0.00001*
LVEF 67 ± 8 66 ± 9 0.61
LV cardiac output (L/min) 5.6 (4.8–6.4) 4.6 (3.8–5.5) 0.0094
Septal curvature 1.09 ± 0.10 −0.20 ± 0.58 <0.00001*
E/A ratio 1.56 (1.23–2.88) 1.33 (1.11–2.36) 0.31
  1. Values are mean ± SD, or median (interquartile range)
  2. *indicates statistical significance (p < 0.0018 following Bonferroni correction)